Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Individually Randomised Controlled Trial to Assess the Efficacy of Artemether-lumefantrine Prophylaxis for Malaria Among Forest Goers in Cambodia

NCT04041973 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT04041973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04041973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Individually Randomised Controlled Trial to Assess the Efficacy of Artemether-lumefantrine Prophylaxis for Malaria Among Forest Goers in Cambodia
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Completed
Start date
March 11, 2020
Completion date
March 17, 2021
Enrollment
1,480 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria